Media Type
Is Your API Right for a Soft Gel Capsule?
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Is Your API Right for a Soft Gel Capsule? Part II in the Pii Soft Gel Capsule Series By: Fei Cai, Senior Scientist, Formulations R&D, and Sundeep Sethia, PhD, Head of R&D, Pii Advances…
Read MorePii to Support US Launch of Weekly and Monthly Injection for Treatment of Moderate to Severe Opioid Use Disorder
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Pii TO SUPPORT US LAUNCH OF WEEKLY AND MONTHLY INJECTION FOR TREATMENT OF MODERATE TO SEVERE OPIOID USE DISORDER HUNT VALLEY, MD, SEPTEMBER 5, 2023—Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization…
Read More2 The Pii Formula, Dosage Form Focus, August 23
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos 2 The Pii Formula, Dosage Form Focus, August 23 This month, The Formula explores dosage forms. While oral solid dosage continues to dominate the market, other viable and lucrative options, such as liquid formulations,…
Read More2 BTN, Dosage Form Focus, August 23
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Dosage Form Focus – 2 By The Numbers – August 2023 More than 2/3 of the drugs prescribed worldwide are oral solids A recent report explores the current market landscape and future opportunity of…
Read MoreHow a CDMO Overcomes Soft Gel Formulation Challenges
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos How a CDMO Overcomes Soft Gel Formulation Challenges Part I in the Pii Soft Gel Capsule Series By: Fei Cai, Senior Scientist, Formulations R&D, and Sundeep Sethia, PhD, Head of R&D, Pii The global…
Read More1 The Pii Formula, Bioavailability, June 23
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos 1 The Pii Formula, Bioavailability, June 23 We are happy to bring you the return of The Formula, a bi-monthly digital publication that takes a deep dive into the challenges of formulating and developing bio/pharmaceuticals. The…
Read More1 BTN, Bioavailability, June 23
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Bioavailability – 1 By The Numbers – June 2023 More Than 75 Bioavailability Enhancement Technologies Are Available The process of bioavailability enhancement is both time and cost intensive to perform in house. This is…
Read MoreSEDDS Optimized Formulation of Hydrophobic Compound
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos How SEDDS Optimized the Formulation of a Hydrophobic Compound A Self-Emulsifying Drug Delivery System (SEDDS) approach was taken by Pii to improve the bioavailability and solubility of a hydrophobic compound. The customer previously had been…
Read MoreChemical Technologies for Bioavailability Enhancement
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Chemical Technologies for Bioavailability Enhancement Lipids and inclusion-complexes can have complementary roles. And while they fulfill similar functions, it is their structural differences that make them suitable for achieving distinct tasks. In pharmaceutical technology,…
Read MoreOral Dose Terminology
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Oral Dose Terminology Active Pharmaceutical Ingredient (API) The API is the biologically active ingredient(s) that produce intended effects on a patient. The physicochemical properties of the API affects the formulation and manufacturing of an…
Read More